Related Experiment Videos
Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients
1Department of Neurology, University of Maryland School of Medicine, Veterans Affairs Medical Center, Baltimore 21201, USA.
Neurology
|August 26, 1998
Summary
Gabapentin effectively treated trigeminal neuralgia in multiple sclerosis (MS) patients. This anticonvulsant provided significant pain relief, even in difficult-to-treat cases.
Area of Science:
- Neurology
- Pharmacology
Background:
- Trigeminal neuralgia is a debilitating condition.
- Multiple sclerosis (MS) can cause trigeminal neuralgia.
- Conventional therapies are often ineffective for refractory cases.
Observation:
- Seven MS patients with refractory trigeminal neuralgia were treated with gabapentin.
- Gabapentin is a recently approved anticonvulsant medication.
Findings:
- Gabapentin achieved complete pain relief in six out of seven patients.
- The seventh patient experienced significant pain reduction with gabapentin.
Implications:
- Gabapentin shows promise as a treatment for trigeminal neuralgia in MS patients.
- This anticonvulsant may be particularly beneficial for refractory trigeminal neuralgia.
- Gabapentin could become a valuable addition to the pharmacologic treatment of trigeminal neuralgia.